TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Faes Farma ( (ES:FAE) ) has provided an update.
Faes Farma has received approval from the European Union for a new manufacturing plant in Derio, Bizkaia, which is set to double its current production capacity. This expansion allows for the immediate commencement of commercialization of medicines across Spain, Europe, and eventually other markets, showcasing the company’s commitment to operational excellence and technological advancement.
More about Faes Farma
Faes Farma operates in the pharmaceutical industry, specializing in the manufacturing of medicines. The company is focused on expanding its production capabilities and market reach, particularly in Europe.
YTD Price Performance: 0.57%
Average Trading Volume: 4,411
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €1.09B
For a thorough assessment of FAE stock, go to TipRanks’ Stock Analysis page.